Efficacy of percutaneous renal revascularization in resistant hypertension patients

Background: Renovascular hypertension is one of the most common potentially curable types of secondary hypertension. Medical therapy alone does not inhibit the progressive loss of renal function. The aim of the present study was to evaluate the efficacy of percutaneous renal revascularization in res...

Full description

Bibliographic Details
Main Authors: Bhushan Bari, Deepak Sadashiv Phalgune, Suhas Hardas
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Indian College of Cardiology
Subjects:
Online Access:http://www.joicc.org/article.asp?issn=1561-8811;year=2020;volume=10;issue=4;spage=181;epage=186;aulast=Bari
_version_ 1827356387194175488
author Bhushan Bari
Deepak Sadashiv Phalgune
Suhas Hardas
author_facet Bhushan Bari
Deepak Sadashiv Phalgune
Suhas Hardas
author_sort Bhushan Bari
collection DOAJ
description Background: Renovascular hypertension is one of the most common potentially curable types of secondary hypertension. Medical therapy alone does not inhibit the progressive loss of renal function. The aim of the present study was to evaluate the efficacy of percutaneous renal revascularization in resistant hypertension patients. Methods: Forty-two patients aged ≥ 45 years with resistant hypertension having renal artery stenosis (>50% luminal narrowing assessed by quantitative renal angiography) undergoing percutaneous transluminal renal angioplasty (PTRA) were included in the study. The primary outcome measures were a response of blood pressure (BP) and the requirement of the number of hypertensive drugs, whereas the secondary outcome measure was to study the correlation of renal vein renin levels (RVRLs) with postrenal angioplasty BP response. Chi-square/Fisher's exact test and unpaired t-test were used to compare qualitative and quantitative variables, respectively. A paired t-test was used for intragroup comparison. Results: The mean systolic BP at 6-month follow-up (159.5 mmHg) was significantly less as compared to baseline (181.3 mmHg) (P = 0.0001). The mean diastolic BP at 6-month follow-up (94.4 mmHg) was significantly less as compared to baseline (106.5 mmHg) (P = 0.0001). The mean number of antihypertensive drugs used at the baseline and 6-month follow-up was 3.4 and 1.8, respectively, which was statistically significant (P = 0.001). There was no significant correlation of RVRL with postrenal angioplasty BP response. Conclusions: In patients with resistant hypertension, PTRA improved BP control and reduced the requirement of antihypertensive drugs.
first_indexed 2024-03-08T05:00:06Z
format Article
id doaj.art-1d51817d68304bb8a5285acdeca0eab9
institution Directory Open Access Journal
issn 1561-8811
2213-3615
language English
last_indexed 2024-03-08T05:00:06Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Indian College of Cardiology
spelling doaj.art-1d51817d68304bb8a5285acdeca0eab92024-02-07T12:54:09ZengWolters Kluwer Medknow PublicationsJournal of Indian College of Cardiology1561-88112213-36152020-01-0110418118610.4103/JICC.JICC_44_20Efficacy of percutaneous renal revascularization in resistant hypertension patientsBhushan BariDeepak Sadashiv PhalguneSuhas HardasBackground: Renovascular hypertension is one of the most common potentially curable types of secondary hypertension. Medical therapy alone does not inhibit the progressive loss of renal function. The aim of the present study was to evaluate the efficacy of percutaneous renal revascularization in resistant hypertension patients. Methods: Forty-two patients aged ≥ 45 years with resistant hypertension having renal artery stenosis (>50% luminal narrowing assessed by quantitative renal angiography) undergoing percutaneous transluminal renal angioplasty (PTRA) were included in the study. The primary outcome measures were a response of blood pressure (BP) and the requirement of the number of hypertensive drugs, whereas the secondary outcome measure was to study the correlation of renal vein renin levels (RVRLs) with postrenal angioplasty BP response. Chi-square/Fisher's exact test and unpaired t-test were used to compare qualitative and quantitative variables, respectively. A paired t-test was used for intragroup comparison. Results: The mean systolic BP at 6-month follow-up (159.5 mmHg) was significantly less as compared to baseline (181.3 mmHg) (P = 0.0001). The mean diastolic BP at 6-month follow-up (94.4 mmHg) was significantly less as compared to baseline (106.5 mmHg) (P = 0.0001). The mean number of antihypertensive drugs used at the baseline and 6-month follow-up was 3.4 and 1.8, respectively, which was statistically significant (P = 0.001). There was no significant correlation of RVRL with postrenal angioplasty BP response. Conclusions: In patients with resistant hypertension, PTRA improved BP control and reduced the requirement of antihypertensive drugs.http://www.joicc.org/article.asp?issn=1561-8811;year=2020;volume=10;issue=4;spage=181;epage=186;aulast=Bariantihypertensive drugspercutaneous transluminal renal angioplastyrenal vein renin levelsresistant hypertension
spellingShingle Bhushan Bari
Deepak Sadashiv Phalgune
Suhas Hardas
Efficacy of percutaneous renal revascularization in resistant hypertension patients
Journal of Indian College of Cardiology
antihypertensive drugs
percutaneous transluminal renal angioplasty
renal vein renin levels
resistant hypertension
title Efficacy of percutaneous renal revascularization in resistant hypertension patients
title_full Efficacy of percutaneous renal revascularization in resistant hypertension patients
title_fullStr Efficacy of percutaneous renal revascularization in resistant hypertension patients
title_full_unstemmed Efficacy of percutaneous renal revascularization in resistant hypertension patients
title_short Efficacy of percutaneous renal revascularization in resistant hypertension patients
title_sort efficacy of percutaneous renal revascularization in resistant hypertension patients
topic antihypertensive drugs
percutaneous transluminal renal angioplasty
renal vein renin levels
resistant hypertension
url http://www.joicc.org/article.asp?issn=1561-8811;year=2020;volume=10;issue=4;spage=181;epage=186;aulast=Bari
work_keys_str_mv AT bhushanbari efficacyofpercutaneousrenalrevascularizationinresistanthypertensionpatients
AT deepaksadashivphalgune efficacyofpercutaneousrenalrevascularizationinresistanthypertensionpatients
AT suhashardas efficacyofpercutaneousrenalrevascularizationinresistanthypertensionpatients